ArticleProceedings of the National Academy of Sciences of the United States of America2018

Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.

Brian C Betts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.